drugset / Trial / NCT01199302
Long-term Safety Study of Brodalumab in Adults With Crohn's Disease
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of long-term treatment with brodalumab in adults with Crohn's disease.
Timeline
- Start
- 2011-02-02
- Primary completion
- 2011-10-18
- Completion
- 2011-10-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brodalumab | Monoclonal antibody | 350 mg | Intravenous |